On the routine MR sequences that we did, we could see acute
ischemic lesions. We see them very well on the diffusion images,
where acute ischemic lesions usually appear with high signal
intensity and restricted diffusion. However, the etiology of these
lesions cannot be derived from these images.
An area of restricted diffusion was seen in the anterior cerebral
artery territory and we concluded it was an ischemic lesion. On
MR angiography we can just see if there is stenosis or vessel
occlusion, but it does not provide us information on the etiology
of this kind of lesion.
So, we decided to perform Black Blood imaging. The presence
and the pattern of vessel wall enhancement on Black Blood
imaging, can help us to determine the etiology of the lesion.
Many studies have shown that Black Blood imaging can help
differentiate vasculitis from other causes of vasculopathy, such as
atherosclerosis, with a high specificity [1-3]. In an atherosclerotic
lesion, vessel wall thickening and enhancement are usually eccentric,
while in vasculitis the wall thickening and enhancement are usually
concentric, homogenous, and in a long portion of the vessel.
Furthermore, this imaging can also be used for the follow-up
of patients whenever their treatment is installed in order to
determine the efficacy of a particular treatment.
In this case the Black Blood imaging helped us to suggest the
diagnosis of HIV-related brain vasculitis.
With the multiple cardiovascular risk factors this patient
had, such as glucose intolerance, arterial hypertension and
hypocholesteremia, his lesions could be atherosclerotic lesions or
vasculitis, conditions which require different treatment. Especially
in this patient with HIV infection causing the vasculitis, treatment
of the two conditions is different.
The results of MRI with Black Blood imaging, helped to choose the
preferred treatment for this patient, which was based on antiviral
medication rather than an antiaggregant or anticoagulation
treatment which is usually given to patients with risk of ischemia
based on atherosclerotic lesions.
One month after beginning the antiviral treatment, the same
MRI examination was repeated and again 8 months after the
beginning of treatment. On follow-up images, we see the
enhancements have almost disappeared.
So in case of this patient, the MRI exam with Black Blood imaging
helped us to give the patient the appropriate treatment and also
allowed us to noninvasively confirm the treatment response.
Black Blood imaging can help us to noninvasively visualize vessel
wall thickening and enhancement patterns that occur in vasculitis,
and help us distinguish it from atherosclerotic lesions. Imaging
techniques such as time-of-flight (TOF) MR angiography are not
very sensitive or specific for this kind of lesions. Other possible
diagnostic methods are intra-arterial angiography or brain
biopsies which are both invasive.
We do not perform this examination with Black Blood imaging
on all patients with ischemic lesions in the brain, because in
most patients the lesion origin is embolic or atherosclerotic. We
typically use it in young patients (less than 60 years old) or those
patients without cardiovascular risk factors. We find it important
to use Black Blood imaging in such cases, because treatment is
different for a patient with vasculitis.
1. Swartz RH, Bhuta SS, Farb RI, Agid R, Willinsky RA, Terbrugge KG, et al. Intracranial arterial wall imaging using high-resolution 3-tesla contrast-enhanced MRI. Neurology. 2009 Feb 17;72(7):627–34.
2. Obusez EC, Hui F, Hajj-Ali RA, Cerejo R, Calabrese LH, Hammad T, et al. Highresolution MRI vessel wall imaging: spatial and temporal patterns of reversible
cerebral vasoconstriction syndrome and central nervous system vasculitis. AJNR Am J Neuroradiol. 2014 Aug;35(8):1527–32.
3. Mossa-Basha M, Hwang WD, De Havenon A, Hippe D, Balu N, Becker KJ, et al.
Multicontrast high-resolution vessel wall magnetic resonance imaging and its value
in differentiating intracranial vasculopathic processes. Stroke J Cereb Circ. 2015
Jun;46(6):1567–73.
4. Cheron J, Wyndham-Thomas C, Sadeghi N, Naeije G. Response of Human
Immunodeficiency Virus-Associated Cerebral Angiitis to the Combined Antiretroviral
Therapy. Front. Neurol., 13 March 2017, doi.org/10.3389/fneur.2017.00095
Results from case studies are not predictive of results in other cases. Results in
other cases may vary.
Philips Black Blood imaging is 3D brain imaging with reduced
intraluminal blood signal1 over the complete imaging volume
in the brain.
It helps you to better differentiate intraluminal blood signal
from other signal, which can enhance diagnostic confidence.
The Black Blood sequence allows
• fast2, isotropic 3D imaging
• higher spatial resolution3
• reformatting in any plane without loss of resolution
1.Compared to our 3D T1W scan without MSE prepulse
2.Compared to our 2D double inversion recovery methods with same full brain coverage
3.Compared to our 2D double inversion recovery methods with same brain coverage and scan time
Philips Black Blood imaging is 3D brain imaging with reduced
intraluminal blood signal1 over the complete imaging volume
in the brain.
It helps you to better differentiate intraluminal blood signal
from other signal, which can enhance diagnostic confidence.
The Black Blood sequence allows
• fast2, isotropic 3D imaging
• higher spatial resolution3
• reformatting in any plane without loss of resolution
1.Compared to our 3D T1W scan without MSE prepulse
2.Compared to our 2D double inversion recovery methods with same full brain coverage
3.Compared to our 2D double inversion recovery methods with same brain coverage and scan time
Our periodic FieldStrength MRI newsletter provides you articles on latest trends and insights, MRI best practices, clinical cases, application tips and more. Subscribe now to receive our free FieldStrength MRI newsletter via e-mail.
